Amlodipine Besylate
NDC 42708-204, Amlodipine besylate, tablet, from QPharma, Inc..
- Product NDC
- 42708-204
- Status
- Listed
- Labeler
- QPharma, Inc.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA078925
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/42708-204 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- AMLODIPINE BESYLATE5 mg/1
Pharmacologic classes
Calcium Channel Antagonists [MoA]; Calcium Channel Blocker [EPC]; Cytochrome P450 3A Inhibitors [MoA]; Dihydropyridine Calcium Channel Blocker [EPC]; Dihydropyridines [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 42708-204-30 | 42708020430 | 30 TABLET in 1 BOTTLE, PLASTIC (42708-204-30) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/5866d1ee-631d-d09e-e063-6294a90abe01
Use it
Look up 42708-204 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/42708-204 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 42708-204. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.